CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 254 filers reported holding CATALYST PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.94 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,692 | +103.1% | 144,699 | +133.6% | 0.00% | +100.0% |
| Q2 2023 | $833 | -70.1% | 61,955 | -63.1% | 0.00% | -75.0% |
| Q1 2023 | $2,782 | -98.0% | 167,787 | +758.3% | 0.00% | – |
| Q2 2022 | $137,000 | -94.8% | 19,548 | -93.8% | 0.00% | -100.0% |
| Q1 2022 | $2,613,000 | +119.2% | 315,151 | +79.0% | 0.00% | +200.0% |
| Q4 2021 | $1,192,000 | +631.3% | 176,049 | +471.6% | 0.00% | – |
| Q3 2021 | $163,000 | -83.5% | 30,800 | -89.6% | 0.00% | -100.0% |
| Q4 2020 | $986,000 | +236.5% | 295,292 | +365.8% | 0.00% | 0.0% |
| Q2 2020 | $293,000 | -89.3% | 63,400 | -91.3% | 0.00% | -83.3% |
| Q4 2019 | $2,742,000 | – | 731,259 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANAKA CAPITAL MANAGEMENT INC | 589,883 | $590,000 | 1.38% |
| Broadfin Capital, LLC | 8,200,000 | $8,610,000 | 0.96% |
| Avoro Capital Advisors LLC | 1,141,149 | $1,198,000 | 0.24% |
| CORRADO ADVISORS, LLC | 190,600 | $200,000 | 0.12% |
| Baker Brothers Advisors | 5,102,153 | $5,357,000 | 0.05% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 756,311 | $794,000 | 0.04% |
| Point72 Asset Management, L.P. | 2,272,816 | $2,386,000 | 0.02% |
| AGRAN LIBBIE | 44,000 | $46,000 | 0.01% |
| COMPTON CAPITAL MANAGEMENT INC /RI | 10,000 | $11,000 | 0.01% |
| KENNEDY CAPITAL MANAGEMENT LLC | 233,171 | $245,000 | 0.00% |